Cargando…

TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism

TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Brigant, Benjamin, Metzinger-Le Meuth, Valérie, Rochette, Jacques, Metzinger, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337287/
https://www.ncbi.nlm.nih.gov/pubmed/30586926
http://dx.doi.org/10.3390/ijms20010067
_version_ 1783388218920534016
author Brigant, Benjamin
Metzinger-Le Meuth, Valérie
Rochette, Jacques
Metzinger, Laurent
author_facet Brigant, Benjamin
Metzinger-Le Meuth, Valérie
Rochette, Jacques
Metzinger, Laurent
author_sort Brigant, Benjamin
collection PubMed
description TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) genetic disorder caused by TRIM37 mutations. TRIM37 is characterized by the presence of a RING domain, B-box motifs, and a coiled-coil region, and its C-terminal part includes the MATH domain specific to TRIM37. MULIBREY nanism is a rare autosomal recessive caused by TRIM37 mutations and characterized by severe pre- and postnatal growth failure. Constrictive pericarditis is the most serious anomaly of the disease and is present in about 20% of patients. The patients have a deregulation of glucose and lipid metabolism, including type 2 diabetes, fatty liver, and hypertension. Puzzlingly, MULIBREY patients, deficient for TRIM37, are plagued with numerous tumors. Among non-MULIBREY patients affected by cancer, a wide variety of cancers are associated with an overexpression of TRIM37. This suggests that normal cells need an optimal equilibrium in TRIM37 expression. Finding a way to keep that balance could lead to potential innovative drugs for MULIBREY nanism, including heart condition and carcinogenesis treatment.
format Online
Article
Text
id pubmed-6337287
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63372872019-01-22 TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism Brigant, Benjamin Metzinger-Le Meuth, Valérie Rochette, Jacques Metzinger, Laurent Int J Mol Sci Review TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) genetic disorder caused by TRIM37 mutations. TRIM37 is characterized by the presence of a RING domain, B-box motifs, and a coiled-coil region, and its C-terminal part includes the MATH domain specific to TRIM37. MULIBREY nanism is a rare autosomal recessive caused by TRIM37 mutations and characterized by severe pre- and postnatal growth failure. Constrictive pericarditis is the most serious anomaly of the disease and is present in about 20% of patients. The patients have a deregulation of glucose and lipid metabolism, including type 2 diabetes, fatty liver, and hypertension. Puzzlingly, MULIBREY patients, deficient for TRIM37, are plagued with numerous tumors. Among non-MULIBREY patients affected by cancer, a wide variety of cancers are associated with an overexpression of TRIM37. This suggests that normal cells need an optimal equilibrium in TRIM37 expression. Finding a way to keep that balance could lead to potential innovative drugs for MULIBREY nanism, including heart condition and carcinogenesis treatment. MDPI 2018-12-24 /pmc/articles/PMC6337287/ /pubmed/30586926 http://dx.doi.org/10.3390/ijms20010067 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Brigant, Benjamin
Metzinger-Le Meuth, Valérie
Rochette, Jacques
Metzinger, Laurent
TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title_full TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title_fullStr TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title_full_unstemmed TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title_short TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
title_sort trimming down to trim37: relevance to inflammation, cardiovascular disorders, and cancer in mulibrey nanism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337287/
https://www.ncbi.nlm.nih.gov/pubmed/30586926
http://dx.doi.org/10.3390/ijms20010067
work_keys_str_mv AT brigantbenjamin trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism
AT metzingerlemeuthvalerie trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism
AT rochettejacques trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism
AT metzingerlaurent trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism